O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, et al. Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo
on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2
Infection: A Randomized Clinical Trial. JAMA 2022 Jan 14. pii: 2788256. doi: 10.1001/jama.2021.24939.
PMID: 35029629